Anti-COVID-19 Vaccination, COVID-19, and Female Contraception: The Exacerbated Risks (Thromboembolism) of the Estrogen-progestin Pill.

MLA

Fajloun, Ziad, et al. “Anti-COVID-19 Vaccination, COVID-19, and Female Contraception: The Exacerbated Risks (Thromboembolism) of the Estrogen-Progestin Pill.” Infectious Disorders Drug Targets, vol. 23, no. 4, 2023, p. e240223214000. EBSCOhost, https://doi.org/10.2174/1871526523666230224094439.

APA

Fajloun, Z., Abi Khattar, Z., Kovacic, H., Legros, C., & Sabatier, J.-M. (2023). Anti-COVID-19 Vaccination, COVID-19, and Female Contraception: The Exacerbated Risks (Thromboembolism) of the Estrogen-progestin Pill. Infectious Disorders Drug Targets, 23(4), e240223214000. https://doi.org/10.2174/1871526523666230224094439

Chicago

Fajloun, Ziad, Ziad Abi Khattar, Hervé Kovacic, Christian Legros, and Jean-Marc Sabatier. 2023. “Anti-COVID-19 Vaccination, COVID-19, and Female Contraception: The Exacerbated Risks (Thromboembolism) of the Estrogen-Progestin Pill.” Infectious Disorders Drug Targets 23 (4): e240223214000. doi:10.2174/1871526523666230224094439.